Comparing the effects of Celecoxib with placebo on inflammatory factors and cognitive impairment in mood disorder patients undergoing electroconvulsive therapy (ECT)

Trial Profile

Comparing the effects of Celecoxib with placebo on inflammatory factors and cognitive impairment in mood disorder patients undergoing electroconvulsive therapy (ECT)

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2014

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Bipolar disorders; Depressive disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 17 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top